autoimmune disease

Biogen quietly whisks away its $544M autoimmune rival to Celgene
Endpoints
Wed, 10/26/16 - 09:28 am
Biogen
Celgene
autoimmune disease
amiselimod
ozanimod
Celgene Is Building an Autoimmune Empire -- and No One Is Talking About It
Motley Fool
Sun, 10/2/16 - 10:19 am
Celgene
autoimmune disease
Otezla
ozanimod
GED-0301
The Most Exciting Drug in Celgene's Pipeline
Motley Fool
Wed, 09/21/16 - 10:46 pm
Celgene
ozanimod
autoimmune disease
Eisai launches research division in Massachusetts aimed at Alzheimer’s, I/O and autoimmune diseases
Endpoints
Thu, 09/15/16 - 09:29 am
Eisai
R&D
Massachusetts
Alzheimer's disease
autoimmune disease
Allergan to acquire Vitae Pharma in an all-cash deal valued at about $639 million
Marketwatch
Wed, 09/14/16 - 09:51 am
Allergan
Vitae
M&A
autoimmune disease
How AbbVie Plans To Replace Humira
Seeking Alpha
Tue, 04/12/16 - 07:43 am
AbbVie
Humira
R&D
autoimmune disease
ABT-122
ABT-494
ABBV-247
ALX-0061
Can Bristol-Myers Win the Autoimmune Market with Padlock Acquisition?
Bidness, ETC
Mon, 03/28/16 - 08:46 am
Bristol-Myers Squibb
Padlock Therapeutics
autoimmune disease
M&A
On a crash course with Celgene? Biogen inks a $544M autoimmune drug deal
Fierce Biotech
Wed, 09/9/15 - 08:12 am
Celgene
Biogen
autoimmune disease
MT-1303
Mitsubishi Tanabe Pharma
AbbVie could end up sidestepping lost sales tied to an expiring patent on Humira in 2017
Motley Fool
Sun, 08/23/15 - 11:40 am
AbbVie
Humira
patents
Imbruvica
autoimmune disease
Autoimmune Drugs to Drive Big Pharma Higher in Coming Years
24/7 Wall St
Mon, 06/8/15 - 09:58 pm
autoimmune disease
AbbVie
JNJ
Eli Lilly
Merck
Bristol-Myers Squibb
Pfizer
Astellas wagers $760M to launch an autoimmune biotech in Cambridge, MA
Fierce Biotech
Wed, 06/3/15 - 11:12 am
Astellas
autoimmune disease
Kanyos Bio
Anokion
Does Celgene Have Another Blockbuster on the Way?
Investopedia
Thu, 03/26/15 - 09:45 pm
Celgene
GED-0301
autoimmune disease
Crohn's Disease
Bristol-Myers buys rights to Novo Nordisk immune system project
Yahoo/Reuters
Tue, 03/24/15 - 10:30 am
Novo Nordisk
Bristol-Myers Squibb
autoimmune disease
Lilly inks a $690M deal to get its hands on an autoimmune drug
Fierce Biotech
Fri, 03/20/15 - 08:18 am
Eli Lilly
Korea
Hanmi Pharmaceutical
autoimmune disease
Sanofi beefs up its autoimmune pipeline with a biotech deal
Fierce Biotech
Wed, 02/18/15 - 10:58 am
Sanofi
Lead Pharma
autoimmune disease
If Pfizer's Right, Hospira Biosimilar Gold Rush Begins This Week
Forbes
Mon, 02/16/15 - 11:55 am
Pfizer
Hospira
M&A
biosimilars
Inflectra
Europe
autoimmune disease
J&J buys bowel drug license option from Isis Pharma for $835 mln
Yahoo/Reuters
Mon, 01/5/15 - 09:07 am
JNJ
Isis Pharmaceuticals
autoimmune disease
inflammatory bowel disease
Virobay tees up a $50M IPO to get a trio of candidates into Phase II
Fierce Biotech
Thu, 09/11/14 - 10:46 am
Virobay
IPOs
autoimmune disease
painkillers
Virobay banks $8M to accelerate its treatments for pain, autoimmunity
Fierce Biotech
Thu, 07/17/14 - 10:05 am
Virobay
autoimmune disease
neuropathic pain
VBY-036
VBY-376
AstraZeneca reports mavrilimumab, sifalimumab studies met primary endpoints
The Fly on the Wall
Mon, 05/12/14 - 11:51 am
mavrilimumab
sifalimumab
AstraZeneca
MedImmune
lupus
autoimmune disease
rheumatoid arthritis

Pages